Acute Coronary Syndrome

Type: Keyphrase
Name: Acute Coronary Syndrome
First reported 3 hours ago - Updated 3 hours ago - 1 reports

ECG Plus Blood Test on ED Arrival Reduced Admissions for Chest Pain

Clinical judgement, combined with an electrocardiogram (ECG) and blood test on arrival, is effective in reducing unnecessary hospital admissions for chest pain, the most common reason for emergency hospital admission, according to a UK study.The latest ... [Published RT Magazine - 3 hours ago]
First reported 15 hours ago - Updated 15 hours ago - 1 reports

Senate committee hears stories on observation status

The Senate Special Committee on Aging Wednesday heard testimony from healthcare leaders on the effects of Medicare observation status on seniors."The real problem comes when a senior citizen learns that they are the one that, after their observation status ... [Published Fierce Healthcare - 15 hours ago]
First reported Jul 30 2014 - Updated Jul 30 2014 - 1 reports

Medicines update (13)

New S2 allergy treatmentThe new Nasonex Allergy Nasal Spray for limited Allergic Rhinitis (AR), is now available over the counter.Available as an S2 medicine since mid-July, Nasonex ALLERGY has an identical formulation to the prescription Nasonex, with ... [Published Pharmacy News - Jul 30 2014]
First reported Jul 30 2014 - Updated Jul 30 2014 - 2 reports

Acute coronary syndrome treatment market to more than triple by 2023

The launch of several drugs with “extraordinary blockbuster potential” will cause the acute coronary syndrome (ACS) treatment market to more than triple in value, from $12.3 billion in 2013 to $43.4 billion by 2023.According to research and consulting ... [Published Pharma Letter - Jul 30 2014]
First reported Jul 29 2014 - Updated Jul 29 2014 - 1 reports

Regado Biosciences to Provide Second Quarter 2014 Financial Results and Corporate Highlights

BASKING RIDGE, N.J.Interested participants and investors may access the conference call by dialing (877) 870-4263 for domestic callers or (412) 317-0790 for international callers. The conference call will be webcast live under the investor relations section ... [Published Bio-Medicine - Jul 29 2014]
First reported Jul 29 2014 - Updated Jul 29 2014 - 1 reports

Myocardial injury in a 41-year-old male treated with methylphenidate: a case report

Elevated cardiac troponin levels are consistent with the diagnosis of an acute coronary syndrome, but may also represent adverse drug reactions. Psychostimulating drugs raise both blood pressure and heart rate, and case reports of sudden death, stroke, ... [Published 7thSpace - Jul 29 2014]
First reported Jul 29 2014 - Updated Jul 29 2014 - 1 reports

Contrast-Induced Acute Kidney Injury After Primary PCI

Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, Mintz GS, Lansky AJ, Moses JW, Stone GW, Leon MB, Dangas G. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial ... [Published Theheart.org - Jul 29 2014]
First reported Jul 28 2014 - Updated Jul 28 2014 - 1 reports

ECG, blood test must for chest pain sufferers: Study

By | IANS India Private Limited/Yahoo India News  –London, July 28 (IANS) Suffering from chest pain? Do not take it lightly for indigestion or gas pain. Better get an electrocardiogram (ECG) and blood test done to rule out the worst and avoid hospita ... [Published Yahoo! Malaysia - Jul 28 2014]
First reported Jul 25 2014 - Updated Jul 25 2014 - 1 reports

The Risk of Ischemic Stroke after an Acute Myocardial Infarction in Patients with Decreased Renal Function

Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, Jafar TH, Heerspink HJ, Mann JF, Matsushita K, Wen CP: Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet 2013;382:339-352.Go AS, Chertow GM, Fan D, McCulloch ... [Published Sexual Development - Jul 25 2014]
First reported Jul 25 2014 - Updated Jul 25 2014 - 1 reports

Heart attack patients could be treated more quickly after Manchester research

Clinical judgement, combined with an electrocardiogram (ECG) and blood test on arrival, is effective in reducing unnecessary hospital admissions for chest pain, a new study shows.The findings of a re group in Manchester, published in the Emergency Medicine ... [Published MyScience - Jul 25 2014]
First reported Jul 22 2014 - Updated Jul 22 2014 - 2 reports

EpiCast Report: Acute Coronary Syndrome (ACS) - Epidemiology Forecast to 2023 - New Study Released

Boston, MA -- ( SBWIRE ) -- 07/22/2014 -- Acute coronary syndrome (ACS) is a serious cardiovascular disease associated with high healthcare costs, frequent recurrences and hospitalizations, and high risks of sudden death and short-term mortality. The ... [Published SBWire - Jul 22 2014]
First reported Jul 14 2014 - Updated Jul 15 2014 - 4 reports

MarketResearchReports.Com: Acute Coronary Syndrome (ACS) - Epidemiology Forecast to 2023, New Report Launched

Lewes, DE -- (SBWIRE) -- 07/15/2014 -- Acute coronary syndrome (ACS) is a serious cardiovascular disease associated with high healthcare costs, frequent recurrences and hospitalizations, and high risks of sudden death and short-term mortality. The ACS ... [Published A.M. Best - Jul 15 2014]

Quotes

Roy Moore , Principal Director at Decision Resources Group, comments: "Health insurance exchanges represent the biggest opportunity for the drug industry since the launch of Part D a decade ago, but this new market is not without challenges. Health plans' desire to control cost and utilization has resulted in new hurdles to access, which ultimately affect the actual drug prescribed. Drug firms must understand the intricacies of specific exchange-based plans to devise successful strategies that will work in this new channel."
"The real problem comes when a senior citizen learns that they are the one that, after their observation status in the hospital, they need nursing home coverage, and despite staying in the hospital for the required three days or more, Medicare won't cover that nursing home stay because the patient was never admitted during that time, but was under observation" said committee chairman Sen. Bill Nelson (D-Fla.)
"As announced earlier, we remain blinded to REGULATE-PCI study data and are awaiting the outcome of the full safety and efficacy analysis, including an analysis of benefit/risk ratio, being performed by our data and safety monitoring board (DSMB). Any recommendation to re-initiate patient enrollment in REGULATE-PCI will be based on the DSMB's conclusions and would always be implemented in agreement with FDA" stated Regado CEO David Mazzo
Infringement of U S Patent Nos. 6,028,071 ( "Purified Compositions of 10-propargyl-10-deazaaminopterin and Methods of Using Same in the Treatment of Tumors" issued February 22, 2000), 7,622,470 ("Treatment of T-cell Lymphoma Using 10-porpargyl-10-deazaaminopterin," issued November 24, 2009), and 8,200,078...

More Content

All (188) | News (152) | Reports (0) | Blogs (30) | Audio/Video (0) | Fact Sheets (2) | Press Releases (3)
sort by: Date | Relevance
A Predictive Equation to Guide Vitamin D Dose i... [Published General Medicine eJournal - 1 hour ago]
ECG Plus Blood Test on ED Arrival Reduced Admis... [Published RT Magazine - 3 hours ago]
Health Exchanges Drive Change In MCO Strategies... [Published Town Hall - 13 hours ago]
Senate committee hears stories on observation s... [Published Fierce Healthcare - 15 hours ago]
REGULATE-PCI Trial Testing Anticoagulant Pegniv... [Published Diagnostic & Invasive Cardiology - Jul 30 2014]
Alirocumab Safely Lowers LDL Cholesterol in Nin... [Published American Journal of Public Health - Jul 30 2014]
Court Report -- Part II - July 2014 #2 [Published JD Supra - Jul 30 2014]
PCI and ACS: Where Do Vorapaxar and Bivalirudin... [Published Theheart.org - Jul 30 2014]
Acute coronary syndrome treatment market to mor... [Published Pharma Letter - Jul 30 2014]
New blockbuster drugs to create massive future ... [Published Pharma Field - Jul 30 2014]
Medicines update (13) [Published Pharmacy News - Jul 30 2014]
Regado Biosciences to Provide Second Quarter 20... [Published Bio-Medicine - Jul 29 2014]
New blockbuster drugs to more than triple acute... [Published European Pharmaceutical Review - Jul 29 2014]
ACS Antithrombotics: Back to the Future? [Published General Medicine eJournal - Jul 29 2014]
New "Blockbusters" Will Triple Acute Coronary S... [Published Pharmaceutical Executive - Jul 29 2014]
Myocardial injury in a 41-year-old male treated... [Published 7thSpace - Jul 29 2014]
Takeda Receives Positive CHMP Opinions for Labe... [Published Nycomed News RSS feed - Jul 29 2014]
Contrast-Induced Acute Kidney Injury After Prim... [Published Theheart.org - Jul 29 2014]
With the right kind of research, we can reduce ... [Published Conversation AU - Jul 28 2014]
Ortho-Clinical Diagnostics, Inc. Signs Agreemen... [Published The CW44 Tampa Bay - Jul 28 2014]
Astute Medical And Ortho-Clinical Diagnostics E... [Published Vision Monday - Jul 28 2014]
ECG, blood test must for chest pain sufferers: ... [Published Yahoo! Malaysia - Jul 28 2014]
Potential of Acarbose to Reduce Cardiovascular ... [Published Theheart.org - Jul 28 2014]
Healthy lifestyle changes – a crucial path to p... [Published Kaieteur News - Jul 27 2014]
Pharma Firms Thrive On Gulf’s Disease Burden [Published Gulf Business - Jul 26 2014]
[Correspondence] International comparisons of a... [Published The Lancet - Jul 25 2014]
The Risk of Ischemic Stroke after an Acute Myoc... [Published Sexual Development - Jul 25 2014]
Heart attack patients could be treated more qui... [Published MyScience - Jul 25 2014]
Effect on CV Risk of HDL Targeted Drug Treatments [Published Theheart.org - Jul 25 2014]
Targeting residual risk: a new approach to trea... [Published British Journal of Cardiology - Jul 25 2014]
1 2 3 4 5 6 7
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Takeda Receives Positive CHMP Opinions for Labe... [Published Nycomed News RSS feed - Jul 29 2014]
ZURICH, July 29, 2014 – Takeda Pharmaceuticals International GmbH (“Takeda”) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued positive opinions for updates ...
[Correspondence] International comparisons of a... [Published The Lancet - Jul 25 2014]
Sheng-Chia Chung and colleagues compared 30-day mortality following admission with acute coronary syndrome to hospitals in either Sweden or England and Wales. ...
Daiichi Sankyo and Eli Lilly and Company: Heart... [Published Business Wire Health News - Jul 23 2014]
GERRARDS CROSS, England--(BUSINESS WIRE)--Revised guidance from the National Institute for Health and Care Excellence (NICE), recommends once-daily, oral antiplatelet prasugrel (Efient®), in combination with aspirin, as a cost-effective option when compared ...
Top stories in health and medicine, July 23, 2014 [Published KevinMD.com - Jul 23 2014]
From  MedPage Today : Salt Consumption Tied to Heart Risk in T2D . Higher salt intake was associated with a greater risk of cardiovascular disease in patients with type 2 diabetes. Three-Drug Cocktail Has Promise in TB . An experimental, three-drug ...
ACS: What Works, What's Coming [Published MedPageToday.com - medical news plus CME for ph ... - Jul 21 2014]
(MedPage Today) -- The basic strategy for acute coronary syndrome might be well established, but questions still abound, leaders in cardiology said. ...
1 2 3 4 5 6

Press Releases

sort by: Date | Relevance
Regado Biosciences Announces $20 Million Privat... [Published PR Newswire - Jan 31 2014]
The Acute Coronary Syndrome 12-Month Posthospit... [Published PR Newswire - Dec 11 2013]
Regado Biosciences, Inc. to Provide Third Quart... [Published PR Newswire - Oct 31 2013]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.